T. Rowe Price Associates

T. Rowe Price Associates’s Caris Life Sciences CAI Stock Holding History

T. Rowe Price Associates’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.2M	Sell	4,371,771 -456,194	-9%	-$9.97M	0.01%	659
2025 Q4	$130M	Sell	4,827,965 -2,096,780	-30%	-$59.1M	0.01%	573
2025 Q3	$209M	Buy	6,924,745 +163,941	+2%	+$5.23M	0.02%	447
2025 Q2	$181M	Buy	+6,760,804	New	+$182M	0.02%	448

Other funds holding CAI

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

Coatue Management

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return